Riskpilot← Back to searchSign inGet full accessMDS Finland Oy
OYActiveY-tunnus 2712303-5Lars Sonckin Kaari 14Manufacture of medical and dental instruments and supplies · NACE 3250Est. 201511 employeeswww.mdsfinland.com
Revenue 2024
EUR 982K
+3% vs 2023
EBITDA margin
18.2%
+64% vs 2023
Equity ratio
66.5%
Financial strength
Net profit 2024
EUR 138K
+72% vs 2023
| Revenue | EUR 982K | +3% |
| EBITDA | EUR 178K | +64% |
| Net profit | EUR 138K | +72% |
| Total assets | EUR 841K | +22% |
| Equity | EUR 559K | +22% |
| Employees | 11 | — |
Legal name
MDS Finland Oy
Y-tunnus number
2712303-5
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
20. syyskuuta 2015
Share capital
EUR 2 500
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Lääketieteellisten laitteiden suunnittelu, valmistus, koulutus ja konsultointi
Address
Lars Sonckin Kaari 14
Phone
+358503801134
Email
jani@mdsfinland.com
Website
www.mdsfinland.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 634 | 774 | 1 073 | 958 | 982 |
| Staff expenses | −406 | −596 | −808 | −718 | −638 |
| EBITDA | 186 | 98 | 145 | 109 | 178 |
| Depreciation & amort. | −16 | −12 | −9 | −7 | −5 |
| EBIT | 171 | 86 | 136 | 102 | 173 |
| Net financials | −2 | −3 | −3 | −2 | −1 |
| Profit before tax | 169 | 83 | 133 | 100 | 173 |
| Tax | 34 | 17 | 28 | 20 | 35 |
| Net profit | 135 | 66 | 106 | 80 | 138 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 478 | 521 | 701 | 691 | 841 |
| Equity | 289 | 332 | 410 | 458 | 559 |
| Long-term debt | 65 | 56 | 45 | 35 | 24 |
| Short-term debt | 124 | 133 | 246 | 198 | 257 |
| Total debt | 190 | 189 | 291 | 233 | 281 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20202024
Equity ratio
66.5%
This company
38.2%
Market median
+74% vs market
20202024
Return on equity
24.7%
This company
18.4%
Market median
+34% vs market
20202024
Net profit margin
14.0%
This company
8.1%
Market median
+73% vs market
20202024
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
20202024
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LP Chief Executive Officer | Chief Executive Officer | 2022 |
IO Confidential Clerk | Confidential Clerk | 2022 |
AK Deputy Member | Deputy Member | 2018 |
JA | Audit | 2024 |
PR Deputy auditor | Deputy auditor | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MDS Finland Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lassi Pekka Nurminen | Chief Executive Officer | 0 companies |
| Iiro Oiva Antero Virtanen | Confidential Clerk | 0 companies |
| Anna Kaisa Virtanen | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |
| Jani Krister Virtanen | Board of Directors | 0 companies |